How likely is it for President Trump's new drug-pricing plan to be implemented? And will we see a return of Elizabeth Holmes' blood-testing ambitions? All that and more on "The Readout LOUD" podcast.

Vera Therapeutics faces a pivotal moment with Phase 3 data expected soon. Depending on the result, the stock may spike or ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

We recently published a list of 12 Best Major Stocks to Buy According to Billionaires. In this article, we are going to take ...

The EO states that while American citizens represent only 5% of the global population, they fund around 75% of global ...

Although inflation appears to be cooling — for now — experts warn that the 2026 COLA may not be enough to keep up with ...

If prescription savings are to be passed on to Americans not on Medicare, Congress likely would have to pass a law to enact ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

Joe Biden's "Inflation Reduction Act" didn't bring down prices – but it is poised to reduce the size of North Carolina's ...

A Delaware County infant with a rare metabolic disease, CPS1 deficiency, was treated at CHOP with a custom CRISPR therapy.

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...